{"version ": "BioASQ6b", "data": [{"title": "BioASQ6b", "paragraphs": [{"qas": [{"id": "56bc751eac7ad10019000013_001", "question": "Name synonym of Acrokeratosis paraneoplastica.", "answers": [{"text": "Bazex syndrome", "answer_start": 31}]}], "context": "Acrokeratosis paraneoplastica (Bazex syndrome): report of a case associated with small cell lung carcinoma and review of the literature."}, {"qas": [{"id": "56bc751eac7ad10019000013_002", "question": "Name synonym of Acrokeratosis paraneoplastica.", "answers": [{"text": "Bazex syndrome", "answer_start": 30}]}], "context": "Acrokeratosis paraneoplastic (Bazex syndrome) is a rare, but distinctive paraneoplastic dermatosis characterized by erythematosquamous lesions located at the acral sites and is most commonly associated with carcinomas of the upper aerodigestive tract. "}, {"qas": [{"id": "56bc751eac7ad10019000013_003", "question": "Name synonym of Acrokeratosis paraneoplastica.", "answers": [{"text": "Bazex syndrome", "answer_start": 0}]}], "context": "Bazex syndrome (acrokeratosis paraneoplastica): persistence of cutaneous lesions after successful treatment of an associated oropharyngeal neoplasm."}, {"qas": [{"id": "56bc751eac7ad10019000013_004", "question": "Name synonym of Acrokeratosis paraneoplastica.", "answers": [{"text": "Bazex syndrome", "answer_start": 30}]}], "context": "Acrokeratosis paraneoplastica Bazex syndrome associated with esophageal squamocellular carcinoma."}, {"qas": [{"id": "56bc751eac7ad10019000013_005", "question": "Name synonym of Acrokeratosis paraneoplastica.", "answers": [{"text": "Bazex syndrome", "answer_start": 31}]}], "context": "Acrokeratosis paraneoplastica (Bazex syndrome) with oropharyngeal squamous cell carcinoma."}, {"qas": [{"id": "56bc751eac7ad10019000013_006", "question": "Name synonym of Acrokeratosis paraneoplastica.", "answers": [{"text": "Bazex syndrome", "answer_start": 31}]}], "context": "Acrokeratosis paraneoplastica: Bazex syndrome."}, {"qas": [{"id": "56bc751eac7ad10019000013_007", "question": "Name synonym of Acrokeratosis paraneoplastica.", "answers": [{"text": "Bazex syndrome", "answer_start": 0}]}], "context": "Bazex syndrome: acrokeratosis paraneoplastica."}, {"qas": [{"id": "56bc751eac7ad10019000013_008", "question": "Name synonym of Acrokeratosis paraneoplastica.", "answers": [{"text": "Bazex syndrome", "answer_start": 0}]}], "context": "Bazex syndrome (acrokeratosis paraneoplastica) is a rare paraneoplastic syndrome that usually occurs in males over 40 years old and is particularly associated with squamous cell carcinoma of the upper aerodigestive tract and adenopathy above the diaphragm.The objectives of our article are (1) to describe a unique case of acrokeratosis paraneoplastica and (2) to review the current literature regarding skin findings, commonly associated neoplasms, and treatment options relative to this condition."}, {"qas": [{"id": "56c1f01def6e394741000045_001", "question": "Orteronel was developed for treatment of which cancer?", "answers": [{"text": "castration-resistant prostate cancer", "answer_start": 73}]}], "context": "Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial."}, {"qas": [{"id": "56c1f01def6e394741000045_002", "question": "Orteronel was developed for treatment of which cancer?", "answers": [{"text": "castration-resistant prostate cancer", "answer_start": 176}]}], "context": "BACKGROUND: Orteronel is an investigational, partially selective inhibitor of CYP 17,20-lyase in the androgen signalling pathway, a validated therapeutic target for metastatic castration-resistant prostate cancer. We assessed orteronel in chemotherapy-naive patients with metastatic castration-resistant prostate cancer."}]}]}